1. Home
  2. News
  3. Tianjin Tianyao Pharmaceuticals Co., Ltd.
  4. Announcement on Outline of the 2024 Annual Performance Briefing
More Tianjin Tianyao Pharmaceuticals Co., Ltd. news
Tianjin Tianyao Pharmaceuticals Co., Ltd.SSE: 600488

Announcement on Outline of the 2024 Annual Performance Briefing

May 17, 2025 · Issued by Tianjin Tianyao Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · May 17, 2025 · 5 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-outline-of-the-2024-annual-performance-briefing-5

Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix

Earlier from Tianjin Tianyao Pharmaceuticals

  • Announcement on Reply to Letter of Inquiry on Post Audit of 2024 Annual ReportMay 13, 2025
  • Announcement on Convening the 2024 Annual Performance BriefingMay 9, 2025
  • Announcement on Receiving Decision for Administrative PenaltyMay 1, 2025
  • Announcement on Provision for ImpairmentApr 29, 2025
  • Announcement on Resolution of the 2024 Annual General MeetingApr 17, 2025

Later from Tianjin Tianyao Pharmaceuticals

  • Announcement on Implementation of Dividend Distribution for 2024Jun 6, 2025
  • Announcement on Resolution of the 17th Meeting of the 9th Board of DirectorsJun 26, 2025
  • Announcement on Subsidiary's Drug Passing Generic Drug Consistency EvaluationJun 27, 2025
  • Semi-annual Earnings Preannouncement for 2025Jul 12, 2025
  • Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025Jul 16, 2025
All Tianjin Tianyao Pharmaceuticals news releases↗

Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.

Follow Tianjin Tianyao Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer